Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sarepta Announces Additional Positive Efficacy For Its Duchenne Muscular Dystrophy Drug

By: TalkMarkets
Shares of Sarepta Therapeutics closed the day up 22% after announcing additional positive phase 2b data for its Duchenne Muscular Dystrophy drug.
Related Stocks:
Sarepta Therapeutics
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.